It was shown, however, that in the presence of TIM3/Gal9 inhibitors, the suppressive effect of the MDSCs on CD8+ cells was abrogated, indicating that the Gal9-TIM3 axis may play a role in the MDS MDSC-mediated T cell suppression. The gene discussed is HAVCR2; the disease is myelodysplastic syndrome.